Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, operates in the field of dialysis care and dialysis products for the treatment of end-stage renal disease. The company owns and operates dialysis clinics providing dialysis treatment, and related laboratory and diagnostic services. As of December 31, 2012, it provided dialysis treatment to 257,916 patients in 3,160 clinics worldwide. The company's laboratory services include blood, urine, and other bodily fluid testing services. It also offers hemodialysis (HD) machines; modular components for dialysis machines; polysulfone dialyzers; bloodlines, HD solutions, concentrates, and granulates; needles; connectors; machines for water treatment; data administration systems; dialysis chairs; phosphate binders; iron products; and other renal drug products, as well as peritoneal dialysis cycler machines and disposable products. In addition, the company also provides adsorbers, which are specialized filters used in other extracorporeal therapies; and distributes specific instruments for vascular access, as well as other supplies, such as bandages, clamps, and injections. Further, it offers dialysis solutions in bags, such as solutions for priming and rinsing HD bloodlines, as well as connection systems for central concentrate supplies and devices for mixing dialysis solutions; and solutions for disinfecting and decalcifying HD machines, fistula needles, and HD catheters, as well as dialysis tubing systems and accessories. Additionally, the company provides peritoneal dialysis systems and solutions comprising continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD). It also offers automated connection technology; and patient management software tools to support both CAPD and APD therapies. The company sells its products through local sales forces, independent distributors, dealers, and sales agents. The company was founded in 1996 and is headquartered in Bad Homburg, Germany.